Be Familiar With Oral Zeposia for Ulcerative Colitis
June 2022
Zeposia (ozanimod) will be a new ORAL, once-daily option for moderate to severe ulcerative colitis (UC) in adults.
Zeposia is already used for multiple sclerosis...but now it's the first sphingosine 1-phosphate (S1P) receptor modulator approved for UC.
It's thought to reduce inflammation by preventing white blood cells from moving out of lymph nodes and into the colon and damaging it.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive